ロード中...
Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
Ulcerative colitis (UC) is a chronic and relapsing inflammatory intestinal disease. Although the morbidity of UC has increased notably in recent years, effective therapeutic treatment remains unsatisfactory. Astragaloside IV (ASI), a monomeric compound isolated from the traditional Chinese medicine...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755457/ https://ncbi.nlm.nih.gov/pubmed/31572532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2019.7907 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|